Increasing the Hydrophobic Component of Poloxamers and the Inclusion of Salt Extend the Release of Bupivacaine from Injectable In Situ Gels, While Common Polymer Additives Have Little EffectGELSIF5.32022-08-025OAAI
Injectable In Situ Gelling System for Sustained Nicotine Delivery as a Replacement Therapy for Smoking CessationGELSIF5.32022-02-122OAAI
Sustained Delivery of Lactoferrin Using Poloxamer Gels for Local Bone Regeneration in a Rat Calvarial Defect ModelMATERIALSIF3.22021-12-286OAAI
Injectable thermoresponsive gels offer sustained dual release of bupivacaine hydrochloride and ketorolac tromethamine for up to two weeksINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22021-07-0120OAAI
Formulation strategies to modulate drug release from poloxamer based in situ gelling systemsEXPERT OPINION ON DRUG DELIVERYIF5.42020-02-2388PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向